| 发明名称 |
Oral extended-release composition |
| 摘要 |
The invention is directed to controlled release formulations containing drugs which are preferably considered sparingly soluble to insoluble and which are suitable for administration to a patient in need of treatment related thereto, and methods of manufacturing the same.
|
| 申请公布号 |
US7476403(B2) |
申请公布日期 |
2009.01.13 |
| 申请号 |
US20040869497 |
申请日期 |
2004.06.16 |
| 申请人 |
ANDRX PHARMACEUTICALS, LLC |
发明人 |
LI BOYONG;NANGIA AVINASH;BROWDER MONTE |
| 分类号 |
A61K9/14;A61K;A61K9/20;A61K9/22;A61K9/24;A61K9/26;A61K9/28;A61K9/48;A61K9/52;A61K9/54 |
主分类号 |
A61K9/14 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
